Ye Wei, Tang Xiaojun, Liu Chu, Wen Chaowei, Li Wei, Lyu Jianxin
Key Laboratory of Laboratory Medicine, Ministry of Education of China, School of Laboratory Medicine and Life Science, Wenzhou Medical University, Wenzhou, Zhejiang, 325035, China.
Anal Bioanal Chem. 2017 Apr;409(10):2727-2735. doi: 10.1007/s00216-017-0217-x. Epub 2017 Feb 2.
To establish a method for accurate quantitation of circulating cell-free mitochondrial DNA (ccf-mtDNA) in plasma by droplet digital PCR (ddPCR), we designed a ddPCR method to determine the copy number of ccf-mtDNA by amplifying mitochondrial ND1 (MT-ND1). To evaluate the sensitivity and specificity of the method, a recombinant pMD18-T plasmid containing MT-ND1 sequences and mtDNA-deleted (ρ) HeLa cells were used, respectively. Subsequently, different plasma samples were prepared for ddPCR to evaluate the feasibility of detecting plasma ccf-mtDNA. In the results, the ddPCR method showed high sensitivity and specificity. When the DNA was extracted from plasma prior to ddPCR, the ccf-mtDNA copy number was higher than that measured without extraction. This difference was not due to a PCR inhibitor, such as EDTA-Na, an anti-coagulant in plasma, because standard EDTA-Na concentration (5 mM) did not significantly inhibit ddPCR reactions. The difference might be attributable to plasma exosomal mtDNA, which was 4.21 ± 0.38 copies/μL of plasma, accounting for ∼19% of plasma ccf-mtDNA. Therefore, ddPCR can quickly and reliably detect ccf-mtDNA from plasma with a prior DNA extraction step, providing for a more accurate detection of ccf-mtDNA. The direct use of plasma as a template in ddPCR is suitable for the detection of exogenous cell-free nucleic acids within plasma, but not of nucleic acids that have a vesicle-associated form, such as exosomal mtDNA. Graphical Abstract Designs of the present work. *: Module 1, #: Module 2, &: Module 3.
为建立一种通过液滴数字PCR(ddPCR)准确定量血浆中循环游离线粒体DNA(ccf-mtDNA)的方法,我们设计了一种ddPCR方法,通过扩增线粒体ND1(MT-ND1)来确定ccf-mtDNA的拷贝数。为评估该方法的灵敏度和特异性,分别使用了含有MT-ND1序列的重组pMD18-T质粒和线粒体DNA缺失(ρ)的HeLa细胞。随后,制备不同的血浆样本用于ddPCR,以评估检测血浆ccf-mtDNA的可行性。结果显示,ddPCR方法具有高灵敏度和特异性。当在ddPCR之前从血浆中提取DNA时,ccf-mtDNA拷贝数高于未提取时测得的拷贝数。这种差异并非由于血浆中的抗凝剂如EDTA-Na等PCR抑制剂所致,因为标准EDTA-Na浓度(5 mM)并未显著抑制ddPCR反应。这种差异可能归因于血浆外泌体mtDNA,其含量为4.21±0.38拷贝/μL血浆,约占血浆ccf-mtDNA的19%。因此,ddPCR可通过预先的DNA提取步骤快速可靠地检测血浆中的ccf-mtDNA,从而更准确地检测ccf-mtDNA。在ddPCR中直接将血浆用作模板适用于检测血浆中的外源游离核酸,但不适用于检测具有囊泡相关形式的核酸,如外泌体mtDNA。本研究工作的设计图摘要。*:模块1,#:模块2,&:模块3。